Eleven Therapeutics
PrivateLast Round
Seed
Aug 2, 2022
Total Funding Raised
$22.4M
Company Overview
Eleven Therapeutics is a biotechnology company that develops RNAi therapeutics by combining artificial intelligence, massively parallel functional assays, and combinatorial chemistry.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Eleven Therapeutics Comparables
Compare Eleven Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Therna Biosciences | 83% | |
| Shape Therapeutics | 82% | |
| Sail Biomedicines | 78% |
Eleven Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Aug 2, 2022 | ||||
| Grant | Dec 18, 2021 |
Key People
Founding team and executive leadership
Eleven Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Seed, Grant |
| NFX | Seed |
| Entrée Capital | Seed |
| Gates Foundation | Seed |
| Harel Insurance Investments & Financial Services | Seed |
| Innovate UK | Grant |
| Entrée Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 2, 2022
$22M round led by Gates Foundation
- Dec 18, 2021
$400K raised from Innovate UK.
Eleven Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Eleven Therapeutics's valuation, stock price, and market status.
Is Eleven Therapeutics a public or private company?
Eleven Therapeutics is a private company.
What is the current stock price of Eleven Therapeutics?
Eleven Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Eleven Therapeutics worth (valuation)?
Valuation information for Eleven Therapeutics is not publicly available.
Can I buy Eleven Therapeutics stock?
Eleven Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Eleven Therapeutics's last funding round?
Eleven Therapeutics's most recent funding round was Seed on August 2, 2022.
Who are the main investors in Eleven Therapeutics?
Key investors in Eleven Therapeutics include Innovate UK, Entrée Capital, Kindred Capital, The Bill & Melinda Gates Foundation Trust.
Will Eleven Therapeutics IPO soon?
No public IPO plans have been announced for Eleven Therapeutics.
How can I track Eleven Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Eleven Therapeutics's secondary market activity and sign up for updates.